Status: Public   Founded:   SEC Filings: Below
Exchange: NASDAQ      Year End: n/a
Symbol: PPCO   Website:          

About Penwest Pharmaceuticals 

Penwest Pharmaceuticals Co. develops pharmaceutical products based on oral drug delivery technologies. The Company is focusing its development efforts principally on products that address diseases of the central nervous system. The two most advanced products in its drug development pipeline are Oxymorphone ER, an extended release formulation of oxymorphone, a narcotic analgesic being developed for twice-a-day dosing in patients with moderate to severe pain requiring continuous, around-the-clock opioid therapy for an extended period of time, and PW2101, a beta blocker intended for the treatment of hypertension and angina. The Company is also developing several additional product candidates in areas, such as edema, epilepsy, schizophrenia and depression.


Penwest Pharmaceuticals Co.

Web Site:


Audio Commentary Coming Soon


Media Center Items (Hi-Res Media Files):

Media Center


NAMC Newswire Items:

 All News

Click for Company Audio Files:

Click for Company Video Files:

Video Files

Click for Company News Feed

RSS Feed Add Feed To My Yahoo Add Feed  to My MSN


NAMC Latest  News NAMC Radio Podcast Wall Street to Main Street


 (c)NAMC Newswire